Sign in

CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205473709
Phone
203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
  1. 4 Option exercise Director acquired 116,575 shares (option exercise)
  2. 4 Option exercise Director acquired 171,622 shares (option exercise)
  3. 4 Open-market buy Director bought 74,782 shares at $5.75 ($429,997)
  4. 4 Open-market buy CEO and CFO bought 114,347 shares at $5.75 ($657,495)
  5. 4 Open-market buy Chief Medical Officer bought 1,739 shares at $5.75 ($9,999)
  6. 4 Open-market buy Director bought 2,608 shares at $5.75 ($14,996)
  7. 424B4 Offering Prospectus
  8. 424B4 Offering Prospectus
  9. 8-K Event Material agreement · Other events
  10. EFFECT Other Notice of Effectiveness
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. CERT Other Certification
  19. 8-A12B Other Registration of Securities
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 13 of 14 · 279 filings